News
ENOV
24.04
+1.52%
0.36
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
NASDAQ · 12h ago
Weekly Report: what happened at ENOV last week (0601-0605)?
Weekly Report · 1d ago
Why Enovis (ENOV) Is Up 9.6% After Beating Q1 Targets And Enhancing Incentive Plan Alignment
Simply Wall St · 1d ago
A Look At Enovis (ENOV) Valuation As Shares Rebound And Long Term Returns Lag
Simply Wall St · 3d ago
Spend $75 or Less to Make Contrarian Bets on These 3 Hard-Hit Value Stocks
Barchart · 6d ago
These 10 small-cap U.S. healthcare giants rank among the market's most attractively valued stocks
Seeking Alpha · 06/01 14:20
Weekly Report: what happened at ENOV last week (0525-0529)?
Weekly Report · 06/01 10:27
Weekly Report: what happened at ENOV last week (0518-0522)?
Weekly Report · 05/25 10:31
A Look At Enovis (ENOV) Valuation After ESOP Shelf Registration For Up To 3,650,000 Shares
Simply Wall St · 05/24 13:29
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?
The Motley Fool · 05/23 00:28
Enovis: Buy Rating Reiterated as Analyst Sees Attractive Risk-Reward, Maintains $52 Price Target Despite BGS Reclassification Risks
TipRanks · 05/21 18:35
Enovis Shareholders Approve Expanded Incentive Plan and Board
TipRanks · 05/19 22:13
Is Enovis’ Improving Q1 2026 Results And Reaffirmed Outlook Altering The Investment Case For ENOV?
Simply Wall St · 05/19 13:32
Weekly Report: what happened at ENOV last week (0511-0515)?
Weekly Report · 05/18 10:31
Enovis (ENOV) Valuation Check After Reaffirmed 2026 Guidance And Solid First Quarter Results
Simply Wall St · 05/14 00:56
Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump
Simply Wall St · 05/12 03:39
Canaccord Genuity Keeps Their Buy Rating on Enovis (ENOV)
TipRanks · 05/11 11:28
Weekly Report: what happened at ENOV last week (0504-0508)?
Weekly Report · 05/11 10:28
Enovis (ENOV) Is Up 16.3% After Reaffirming 2026 Outlook And Narrowing Losses – Has The Bull Case Changed?
Simply Wall St · 05/10 16:26
Enovis Earnings Call Highlights Recon Strength, Caution
TipRanks · 05/09 01:37
More
Webull provides a variety of real-time ENOV stock news. You can receive the latest news about Enovis Corp through multiple platforms. This information may help you make smarter investment decisions.
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).